To systematically evaluate the biological significance of EIF3M in prognosis across multiple cancer types, we performed survival curve analysis using the GEPIA2 database to investigate the clinical relevance between its expression levels and patient survival outcomes. The gene discussed is EIF3M; the disease is cancer.